Simon Quick Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $675K | Buy |
5,250
+304
| +6% | +$35.6K | 0.03% | 236 |
|
|
2026
Q1 | $595K | Sell |
4,946
-1,517
| -23% | -$175K | 0.03% | 229 |
|
|
2025
Q4 | $680K | Buy |
6,463
+583
| +10% | +$54.7K | 0.03% | 226 |
|
|
2025
Q3 | $493K | Buy |
5,880
+602
| +11% | +$49.6K | 0.02% | 271 |
|
|
2025
Q2 | $418K | Sell |
5,278
-11,972
| -69% | -$952K | 0.02% | 261 |
|
|
2025
Q1 | $1.55M | Buy |
17,250
+2,326
| +16% | +$217K | 0.09% | 106 |
|
|
2024
Q4 | $1.48M | Buy |
14,924
+1,012
| +7% | +$104K | 0.09% | 97 |
|
|
2024
Q3 | $1.58M | Buy |
13,912
+550
| +4% | +$65.3K | 0.1% | 93 |
|
|
2024
Q2 | $1.65M | Buy |
13,362
+2,032
| +18% | +$262K | 0.12% | 88 |
|
|
2024
Q1 | $1.49M | Buy |
11,330
+2,780
| +33% | +$343K | 0.11% | 92 |
|
|
2023
Q4 | $932K | Sell |
8,550
-2,594
| -23% | -$269K | 0.08% | 116 |
|
|
2023
Q3 | $1.15M | Buy |
11,144
+1,068
| +11% | +$115K | 0.11% | 98 |
|
|
2023
Q2 | $1.16M | Sell |
10,076
-1,332
| -12% | -$151K | 0.11% | 88 |
|
|
2023
Q1 | $1.21M | Buy |
11,408
+6,059
| +113% | +$654K | 0.13% | 85 |
|
|
2022
Q4 | $593K | Buy |
5,349
+1,461
| +38% | +$149K | 0.07% | 122 |
|
|
2022
Q3 | $335K | Buy |
3,888
+573
| +17% | +$51.2K | 0.05% | 141 |
|
|
2022
Q2 | $290K | Sell |
3,315
-3,429
| -51% | -$304K | 0.04% | 140 |
|
|
2022
Q1 | $553K | Sell |
6,744
-8,902
| -57% | -$702K | 0.16% | 60 |
|
|
2021
Q4 | $1.2M | Buy |
15,646
+7,244
| +86% | +$577K | 0.32% | 39 |
|
|
2021
Q3 | $631K | Buy |
8,402
+763
| +10% | +$58K | 0.16% | 65 |
|
|
2021
Q2 | $594K | Sell |
7,639
-681
| -8% | -$50.7K | 0.16% | 59 |
|
|
2021
Q1 | $612K | Sell |
8,320
-1,483
| -15% | -$109K | 0.18% | 56 |
|
|
2020
Q4 | $765K | Buy |
9,803
+3,107
| +46% | +$238K | 0.23% | 43 |
|
|
2020
Q3 | $530K | Sell |
6,696
-806
| -11% | -$63.1K | 0.15% | 46 |
|
|
2020
Q2 | $554K | Buy |
7,502
+187
| +3% | +$14.1K | 0.21% | 42 |
|
|
2020
Q1 | $537K | Sell |
7,315
-956
| -12% | -$75.1K | 0.2% | 43 |
|
|
2019
Q4 | $718K | Buy |
8,271
+231
| +3% | +$19K | 0.26% | 46 |
|
|
2019
Q3 | $646K | Buy |
8,040
+3,024
| +60% | +$242K | 0.29% | 35 |
|
|
2019
Q2 | $401K | Sell |
5,016
-2,609
| -34% | -$200K | 0.2% | 38 |
|
|
2019
Q1 | $605K | Buy |
7,625
+873
| +13% | +$65.3K | 0.25% | 36 |
|
|
2018
Q4 | $492K | Sell |
6,752
-35
| -0.5% | -$2.47K | 0.18% | 45 |
|
|
2018
Q3 | $459K | Sell |
6,787
-3,552
| -34% | -$226K | 0.19% | 43 |
|
|
2018
Q2 | $598K | Sell |
10,339
-2,348
| -19% | -$132K | 0.25% | 36 |
|
|
2018
Q1 | $659K | Buy |
12,687
+41
| +0.3% | +$2.21K | 0.28% | 38 |
|
|
2017
Q4 | $715K | Sell |
12,646
-3,699
| -23% | -$205K | 0.32% | 39 |
|
|
2017
Q3 | $999K | Buy |
16,345
+344
| +2% | +$20.9K | 0.36% | 44 |
|
|
2017
Q2 | $979K | Buy |
16,001
+4,543
| +40% | +$277K | 0.55% | 29 |
|
|
2017
Q1 | $695K | Buy |
11,458
+3,876
| +51% | +$235K | 0.41% | 37 |
|
|
2016
Q4 | $426K | Buy |
+7,582
| New | +$444K | 0.32% | 59 |
|
Other funds holding MRK
ECSS
Simon Quick Advisors's MRK Position: Q2 2026 in Review
Simon Quick Advisors increased its Merck (MRK) stake by 6.1% in Q2 2026, buying an estimated $35.6K and bringing the position to 5,250 shares worth $675K. The position accounts for 0.03% of the portfolio, ranked #236.
Simon Quick Advisors first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.65M in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Simon Quick Advisors held 5,250 shares of Merck worth $675K as of Q2 2026.
- Simon Quick Advisors bought 304 Merck shares in Q2 2026, an estimated $35.6K.
- Merck made up 0.03% of Simon Quick Advisors's portfolio in Q2 2026, its #236 holding.
- Simon Quick Advisors first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- Simon Quick Advisors's Merck position peaked at $1.65M in Q2 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Simon Quick Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.